If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Claudia Sandomenico is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
oxaliplatin Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Leucovorin Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 585 Citations
  • 15 h-Index
  • 37 Article
  • 1 Review article

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

Morabito, A., Piccirillo, M. C., Maione, P., Luciani, A., Cavanna, L., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Morgillo, F., Burgio, M. A., Ferrara, D., Rosetti, F., Bianco, R., Artioli, F., Cortinovis, D., Gebbia, V., Fregoni, V., Mencoboni, M., Sandomenico, C. & 10 others, Rossi, A., Montanino, A., Manzo, A., Rocco, G., Arenare, L., Daniele, G., Signoriello, S., Gallo, C., Perrone, F. & Gridelli, C., Jul 1 2019, In : Lung Cancer. 133, p. 62-68 7 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Cisplatin
Quality of Life
Drug Therapy
Mouth

Pembrolizumab in lung cancer: current evidence and future perspectives

Palumbo, G., Carillio, G., Manzo, A., Montanino, A., Sforza, V., Costanzo, R., Sandomenico, C., Manna, C. L., Luca, G. D., Piccirillo, M. C., Daniele, G., Cecio, R. D., Botti, G., Totaro, G., Muto, P., Picone, C., Esposito, G., Normanno, N. & Morabito, A., 2019, In : Future Oncology.

Research output: Contribution to journalArticle

Lung Neoplasms
Ligands
Non-Small Cell Lung Carcinoma
Antibodies, Monoclonal, Humanized
Biological Factors
3 Citations (Scopus)

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

Morabito, A., Daniele, G., Costanzo, R., Favaretto, A. G., Filipazzi, V., Rossi, A., Gebbia, V., Castiglione, F., Cavanna, L., Maiello, E., Sandomenico, C., Bonanno, L., Piazza, E., Maione, P., Piccirillo, M. C., Di Maio, M., Rocco, G., Gallo, C., Perrone, F. & Gridelli, C., Jun 1 2017, In : Lung Cancer. 108, p. 15-21 7 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Etoposide
Cisplatin
Disease-Free Survival
Drug Therapy
3 Citations (Scopus)

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

Morabito, A., Daniele, G., Costanzo, R., Favaretto, A. G., Filipazzi, V., Rossi, A., Gebbia, V., Castiglione, F., Cavanna, L., Maiello, E., Sandomenico, C., Bonanno, L., Piazza, E., Maione, P., Piccirillo, M. C., Di Maio, M., Rocco, G., Gallo, C., Perrone, F. & Gridelli, C., Jun 2017, In : Lung Cancer. 108, p. 15-21 7 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Etoposide
Cisplatin
Disease-Free Survival
Drug Therapy
3 Citations (Scopus)

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

Morabito, A., Daniele, G., Costanzo, R., Favaretto, A. G., Filipazzi, V., Rossi, A., Gebbia, V., Castiglione, F., Cavanna, L., Maiello, E., Sandomenico, C., Bonanno, L., Piazza, E., Maione, P., Piccirillo, M. C., Di Maio, M., Rocco, G., Gallo, C., Perrone, F. & Gridelli, C., 2017, In : Lung Cancer. 108, p. 15-21 7 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Etoposide
Cisplatin
Disease-Free Survival
Drug Therapy